Pharma Law
was founded by Nicola Blakeley, CEO and leading life sciences solicitor with more than 20 years commercial strategy and 'Top 20 Big Pharma' experience, to provide a flexible business solution for specialist legal, compliance, regulatory and commercial strategy services in the Life Science and Pharmaceutical industries.
At Pharma Law, we know the A to Z of your industry like the back of our hands. Providing practical 'end to end' legal and compliance Services and Solutions
from early clinical development through to end of life cycle management for multi billion blockbuster products facing patent expiry, and every s tep in between:
Advertising, Marketing & PromotionAnti-corruptionAnti-trust & Competition LawAlliances, Collaborations & Joint WorkingClinical Research, IIS & Post-MA studiesCodes of Practice & Regulatory DisputesCommercial Contracting & Procurement Compliance & EthicsCorporate Policies & ProceduresData Privacy & GDPRDigital Communications & Social MediaDocument Drafting, Review and ApprovalEvents, Conferences & CongressHCP, HCO & Professional ServicesHomecare Delivery & Patient ServicesIntellectual PropertyMarket Access, Pricing & ReimbursementMeetings & HospitalityMerger, Acquisition and Divestment PatientPatient Advocacy and Patient OrganisationsPublications & Professional EndorsementScientific Services & Ad BoardsSponsorship, Grants & DonationsWholesale, Distribution, Warehousing & Logistics
Within the past decade, our Founder has personally managed
the legal affairs for
7 of the 'top 20' 2019 global blockbuster pharmaceutical products*
for the UK & Ireland markets, helped facilitate market entry for novel products in in CV, Immunology and Oncology, with many therapy line extensions, pricing and reimbursement, and managed patent expiry for blockbusters in CV, Respiratory, Immunology:
Arthritis, AS, UC, Crohns, Psoriasis adalimumabNeovascular (wet) Age-related Macular
Degeneration afliberceptStroke and Systemic Embolism riveroxaban, apixaban and dabigatranNTRK gene fusion- positive solid tumours larotrectinibAndrogen-receptor inhibitor darolutamideMelanoma
nivolumabHIV bictegravir/emtricitabine/tenofovir alafenamide, emtricitabine and tenofovir alafenamide and elvitegravir, cobicistant, emtricitabine and tenofovir alafenamide fumarateCOPD and Asthma tiotropium bromideParkinsons pramipexole and intestinal levadopa / carbidopaMultiple Sclerosis delta-9-tetrahydrocannibinol and cannabidiol
* https://www.fiercepharma.com/special-report/top-20-drugs-by-global-sales-2019
Interested to learn more Contact us